The Groninger capacity has an output of 48k units p/h
Capacity is dependent on many factors but with all things being equal, IDT's filling capacity is similar to CSL based on recent feasibility study.
IDT could do the formulation and fill/finish activities for their vaccine.
Novavax is extremely close to approval in UK and then Australia with phase III trials showing incredibly high efficacy and less side effects than current vaccines
Novavax will be the booster of choice in the Asia Pacific region and common sense suggests that IDT will be the manufacturer here.
Novavax and IDT Partnership, page-2
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.39M | |||
| Open | High | Low | Value | Volume |
| 9.5¢ | 9.5¢ | 8.7¢ | $27.60K | 293.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.5¢ | 99165 | 1 |
View Market Depth
| Last trade - 15.30pm 19/04/2024 (20 minute delay) ? |
|
|||||
|
Last
9.3¢ |
Change
0.000 ( 1.06 %) |
||||
| Open | High | Low | Volume | ||
| 9.4¢ | 9.4¢ | 9.3¢ | 4875 | ||
| Last updated 11.04am 19/04/2024 ? | |||||
| IDT (ASX) Chart |